These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening. Sanchez BA, Varotti FP, Rodrigues FG, Carvalho LH. J Microbiol Methods; 2007 Jun; 69(3):518-22. PubMed ID: 17466399 [Abstract] [Full Text] [Related]
23. [Successful in vitro culture of Plasmodium falciparum gametocytes]. Rada AM, Moreno C, Blair S. Biomedica; 2008 Dec; 28(4):607-15. PubMed ID: 19462566 [Abstract] [Full Text] [Related]
24. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Basco LK. Am J Trop Med Hyg; 2004 May; 70(5):474-80. PubMed ID: 15155978 [Abstract] [Full Text] [Related]
25. Effect of metalloprotease inhibitors on invasion of red blood cell by Plasmodium falciparum. Kitjaroentham A, Suthiphongchai T, Wilairat P. Acta Trop; 2006 Jan; 97(1):5-9. PubMed ID: 16168946 [Abstract] [Full Text] [Related]
26. Effects of neoglycoproteins on penetration of Plasmodium falciparum merozoites into erythrocytes in vitro. Schulman S, Lee YC, Vanderberg JP. J Parasitol; 1984 Apr; 70(2):213-6. PubMed ID: 6381683 [Abstract] [Full Text] [Related]
27. Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium sp. Lazaro JE, Nitcheu J, Mahmoudi N, Ibana JA, Mangalindan GC, Black GP, Howard-Jones AG, Moore CG, Thomas DA, Mazier D, Ireland CM, Concepcion GP, Murphy PJ, Diquet B. J Antibiot (Tokyo); 2006 Sep; 59(9):583-90. PubMed ID: 17136890 [Abstract] [Full Text] [Related]
28. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Gilson PR, Crabb BS. Int J Parasitol; 2009 Jan; 39(1):91-6. PubMed ID: 18952091 [Abstract] [Full Text] [Related]
29. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'. Valla A, Valla B, Cartier D, Le Guillou R, Labia R, Florent L, Charneau S, Schrevel J, Potier P. Eur J Med Chem; 2006 Jan; 41(1):142-6. PubMed ID: 16274873 [Abstract] [Full Text] [Related]
30. [Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Le Bras J, Andrieu B, Hatin I, Savel J, Coulaud JP. Pathol Biol (Paris); 1984 May; 32(5):463-6. PubMed ID: 6377209 [Abstract] [Full Text] [Related]
31. Disruption of lipid rafts by lidocaine inhibits erythrocyte invasion by Plasmodium falciparum. Koshino I, Takakuwa Y. Exp Parasitol; 2009 Dec; 123(4):381-3. PubMed ID: 19733566 [Abstract] [Full Text] [Related]
32. Absence of effect of retinol on the in vitro development of Plasmodium falciparum. Samba DC, Basco LK, Bleiberg-Daniel F, Lemmonier D, Le Bras J. Int J Vitam Nutr Res; 1992 Dec; 62(1):99-100. PubMed ID: 1587714 [No Abstract] [Full Text] [Related]
33. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain. Jung SY, Zheng B, Choi YY, Soh BY, Kim SY, Park KI, Park H. Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368 [Abstract] [Full Text] [Related]
34. Synergistic enhancement of a copper chelator, bathocuproine disulphonate, and cysteine on in vitro growth of Plasmodium falciparum in glucose-6-phosphate dehydrogenase-deficient erythrocytes. Tantular IS, Jalloh A, Pusarawati S, Azuno Y, Lin K, Kerong H, Dachlan YP, Ishii A, Kawamoto F. Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):301-9. PubMed ID: 12971554 [Abstract] [Full Text] [Related]
35. An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro. Quashie NB, de Koning HP, Ranford-Cartwright LC. Malar J; 2006 Oct 31; 5():95. PubMed ID: 17076900 [Abstract] [Full Text] [Related]
36. Plasmodium falciparum: growth response to potassium channel blocking compounds. Waller KL, Kim K, McDonald TV. Exp Parasitol; 2008 Nov 31; 120(3):280-5. PubMed ID: 18703053 [Abstract] [Full Text] [Related]
37. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum. Guetzoyan L, Ramiandrasoa F, Dorizon H, Desprez C, Bridoux A, Rogier C, Pradines B, Perrée-Fauvet M. Bioorg Med Chem; 2007 May 01; 15(9):3278-89. PubMed ID: 17339112 [Abstract] [Full Text] [Related]
38. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites. Loyevsky M, Cabantchik ZI. Mol Pharmacol; 1994 Mar 01; 45(3):446-52. PubMed ID: 8145731 [Abstract] [Full Text] [Related]
39. Antimalarial activity of anthothecol derived from Khaya anthotheca (Meliaceae). Lee SE, Kim MR, Kim JH, Takeoka GR, Kim TW, Park BS. Phytomedicine; 2008 Jun 01; 15(6-7):533-5. PubMed ID: 17913482 [Abstract] [Full Text] [Related]
40. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Andricopulo AD, Akoachere MB, Krogh R, Nickel C, McLeish MJ, Kenyon GL, Arscott LD, Williams CH, Davioud-Charvet E, Becker K. Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2283-92. PubMed ID: 16458512 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]